Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 4/2017

01-04-2017 | Original Article

Comparing the symptom experience of cancer patients and non-cancer patients

Authors: Teresa L. Deshields, Valentina Penalba, Jingxa Liu, James Avery

Published in: Supportive Care in Cancer | Issue 4/2017

Login to get access

Abstract

Purpose

Symptom burden is an established concept in oncology encompassing the presence and severity of symptoms experienced by cancer patients. Few studies have examined differences in symptom burden between cancer patients and non-cancer patients. This study seeks to examine the differences in symptom burden between cancer patients (CP) and non-cancer patients (NCP) in order to better understand symptom burden in both populations.

Methods

Two groups of patients completed the Memorial Symptom Assessment Scale: 301 patients from a general medical clinic and 558 cancer patients from a cancer tumor registry. Participants provided demographic information—age, race/ethnicity, and sex and completed the Memorial Symptom Assessment Scale. Medical comorbidity was also measured.

Results

Most symptoms were more common in CP, except for pain, which was more prevalent in the NCP (45% of CP vs. 54% of NCP, p < .05). There was no difference in prevalence for the following symptoms: dry mouth, mouth sores, feeling nervous, worry, cough, and dizziness. The CP had greater mean MSAS Total scores (0.53 vs. 0.43, p < .01), number of symptoms (9.11 vs. 6.13, p < .01), and psychological subscale scores (0.77 vs. 0.64, p < .05). There was no difference by group in the physical nor the GDI subscale scores.

Conclusion

The results of this study support the perception that cancer patients have greater symptom burden. There were some unexpected results, particularly in terms of pain, which was more common in NCP and other symptoms that were experienced equally in both patient populations.
Literature
1.
American Cancer Society (2016) Cancer Facts & Figures 2016. American Cancer Society, Atlanta
2.
Institute of Medicine and National Research Council (2006) From cancer patient to cancer survivor: lost in transition. National Academies Press, Washington, DC
3.
Cleeland CS (2007) Symptom burden: multiple symptoms and their impact as patient-reported outcomes. J Natl Cancer Inst Monogr 37:16–21CrossRef
4.
Wu H-S, Harden JK (2015) Symptom burden and quality of life in survivorship: a review of the literature. Cancer Nurs 38(1):E29–E54CrossRef
5.
Deshields TL, Potter P, Olsen S, Liu J, Dye L (2011) Documenting the symptom experience of cancer patients. J Support Oncol 9(6):216–223CrossRef
6.
Deshields T, Potter P, Olsen S, Liu J (2014) The persistence of symptom burden: symptom experience and quality of life of cancer patients across one year. Support Care Cancer 22(4):1089–1096CrossRef
7.
Marvel MK, Epstein RM, Flowers K, Beckman HB (1999) Soliciting the patient’s agenda: have we improved? JAMA 281(3):283–287CrossRef
8.
Tai-Seale M, McGuire T, Zhang W (2007) Time allocation in primary care visits. Health Serv Res 42(5):871–894CrossRef
9.
Haas LJ, Glazer K, Houchins J, Terry S (2006) Improving the effectiveness of the medical visit: a brief visit-structuring workshop changes patients’ perceptions of primary care visits. Patient Educ Couns 62(3):374–378CrossRef
10.
Kroenke K, Jackson JL, Chamberlin J (1997) Depressive and anxiety disorders in patients presenting with physical complaints: clinical predictors and outcome. Am J Med 103(5):339–347CrossRef
11.
Bausewein C, Booth S, Gysels M et al (2010) Understanding breathlessness: cross-sectional comparison of symptom burden and palliative care needs in chronic obstructive pulmonary disease and cancer. J Palliat Med 13(9):1109–1118CrossRef
12.
Goodridge D, Lawson J, Duggleby W et al (2008) Health care utilization of patients with chronic obstructive pulmonary disease and lung cancer in the last 12 months of life. Respir Med 102(6):885–891CrossRef
13.
Bekelman DB, Rumsfeld JS, Havranek EP et al (2009) Symptom burden, depression, and spiritual well-being: a comparison of heart failure and advanced cancer patients. J Gen Intern Med 24(5):592–598CrossRef
14.
Malik FA, Gysels M, Higginson IJ (2013) Living with breathlessness: a survey of caregivers of breathless patients with lung cancer or heart failure. Palliat Med 27(7):64–56CrossRef
15.
Sherman DW, Ye XY, Beyer McSherry C et al (2007) Symptom assessment of patients with advanced cancer and AIDS and their family caregivers: the results of a quality-of-life pilot study. Am J Hosp Palliat Care 24(5):350–365CrossRef
16.
Basch E, Reeve BB, Mitchell SA et al (2014) Development of the National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Natl Cancer Inst 106(9):1–11CrossRef
17.
Steindal SA, Bredal IS, Sorbye LW et al (2011) Pain control at the end of life: a comparative study of hospitalized cancer and noncancer patients. Scand J Caring Sci 25(4):771–779CrossRef
18.
Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383CrossRef
19.
Piccirillo JF, Creech CM, Zequeira R (1999) Anderson S, Johnston AS. Inclusion of comorbidity into oncology data registries. J Registry Manag 26(2):66–70
20.
Portenoy RK, Thaler HT, Kornblith AB et al (1994) The memorial symptom assessment scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 30A(9):1326–1236CrossRef
21.
Tranmer JE, Heyland D, Dudgeon D et al (2003) Measuring the symptom experience of seriously ill cancer and non-cancer hospitalized patients near the end of life with the memorial symptom assessment scale. J Pain Symptom Manag 25(5):420–429CrossRef
22.
Esther Kim JE, Dodd MJ, Aouizerat BE et al (2009) Review of the prevalence and impact of multiple symptoms in oncology patients. J Pain Symptom Manag 37(4):715–736CrossRef
23.
Chang VT, Hwang SS, Feuerman M et al (2000) Symptom and quality of life survey of medical oncology patients at a veteran’s affairs medical center: a role for symptom assessment. Cancer 88(5):1175–1183CrossRef
24.
Van den Beuken-van Everdingen MHJ, De Rijke JM, Kessels AG et al (2007) Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol 18(9):1437–1449CrossRef
25.
Kroenke K. A (2014) Practical and evidence-based approach to common symptoms. Ann Intern Med 161:579–586CrossRef
26.
Schumacher S, Rief W, Brähler E et al (2014) Disagreement in doctor’s and patient’s rating about medically unexplained symptoms and health care use. Int J Behav Med 20(1):30–37CrossRef
27.
Fries JF, Koop CE, Beadle CE et al (1993) Reducing health care costs by reducing the need and demand for medical services. N Engl J Med 329:321–325CrossRef
28.
Jensen SB, Pedersen AM, Vissink A et al (2010) A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Support Care Cancer 18(8):1039–1060CrossRef
29.
Chambers MS, Garden AS, Kies MS, Martin JW (2004) Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management. Head & Neck 26(9):796–807CrossRef
30.
Barkokebas A1, Silva IH, de Andrade SC et al (2014) Impact of oral mucositis on oral-health-related quality of life of patients diagnosed with cancer. J Oral Pathol Med 44(9):746–751CrossRef
31.
Smith RG, Burtner AP (1994) Oral side-effects of the most frequently prescribed drugs. Spec Care Dentist 14(3):96–102CrossRef
32.
Reyes-Gibby C, Anderson K, Morrow P et al (2012) Depressive symptoms and health-related quality of life in breast cancer survivors. J Women's Health 21(3):311–318CrossRef
33.
Graça Pereira M1, Figueiredo AP, Fincham FD (2012) Anxiety, depression, traumatic stress and quality of life in colorectal cancer after different treatments: a study with Portuguese patients and their partners. Eur J Oncol Nurs 16(3):227–232CrossRef
34.
Collins C (2009) Integrating behavioral and mental health services into the primary care setting. N C Med J 70:248–252PubMed
35.
Perkins A (1994) Saving money by reducing stress. Harvard Bus Rev 72:12
36.
Cummings N, VandenBos G (1981) The twenty years Kaiser-Permanente experience with psychotherapy and medical utilization: implications for national health policy and national health insurance. Health Policy Q 1(2):159–175PubMed
37.
38.
39.
Nesic VS, Petrovic AM, Sipetic SB et al (2012) Comparison of the adult comorbidity evaluation 27 and the Charlson comorbidity indices in patients with laryngeal squamous cell carcinoma. J Laryngol Otol 126:516–524CrossRef
40.
Kallogjeri D, Gaynor SM, Piccirillo ML et al (2014) Comparison of comorbidity collection methods. J Am Coll Surg 219(2):245–255CrossRef
Metadata
Title
Comparing the symptom experience of cancer patients and non-cancer patients
Authors
Teresa L. Deshields
Valentina Penalba
Jingxa Liu
James Avery
Publication date
01-04-2017
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 4/2017
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-016-3498-2

Other articles of this Issue 4/2017

Supportive Care in Cancer 4/2017 Go to the issue

Original Article

Sustainable impact of an individualized exercise program on physical activity level and fatigue syndrome on breast cancer patients in two German rehabilitation centers

Review Article

Review of yoga therapy during cancer treatment

Original Article

Dental health status and patient-reported outcomes at baseline in patients participating in the osteonecrosis of the jaw registry study, SWOG S0702

Original Article

Validation of the Chinese version of functional assessment of anorexia-cachexia therapy (FAACT) scale for measuring quality of life in cancer patients with cachexia

Original Article

The importance of evidence-based supportive care practice guidelines in childhood cancer—a plea for their development and implementation

Original Article

Physicians’ practice of discussing fertility preservation with cancer patients and the associated attitudes and barriers
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits